Ushbu ishga iqtibos qilgan ishlar

3 ta ish

Ish: Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer

1. The Use of Nivolumab in Colorectal Cancer with Lynch Syndrome. A Case Report

   G. G. Khakimova, A. Tryakin, G.A. Khakimov Khakimov

   MaqolaGenetic factors in colorectal cancerMalignant tumours20200 iqtibos

   ABIABI:AkademIndex/openalex/2020.article.001794

2. Translational research of new developments in targeted therapy of colorectal cancer

   Lei Yang, N. E. Atakhanova, Meryelem Tania Churampi Arellano +9

   Sharh maqolaColorectal Cancer Treatments and StudiesPathology - Research and Practice20230 iqtibos

   ABIABI:AkademIndex/openalex/2023.review-article.000055

3. Senescence-related signatures predict prognosis and response to immunotherapy in colon cancer

   Xiaoshan Hu, Xiongjie Zhu, Yifan Chen +7

   MaqolaTelomeres, Telomerase, and SenescenceJournal of Gastrointestinal Oncology20240 iqtibos

   ABIABI:AkademIndex/openalex/2024.article.002648